1600 1620 siwanon jirawatnotai
Transcript of 1600 1620 siwanon jirawatnotai
Siwanon Jirawatnotai, Ph.D.Siriraj Laboratory of Systems Pharmacology,Dept of Pharmacology, Siriraj Medical School
A Direct Role of Cyclin D1 in DNA Repair
Cyclin D1 is a cell cycle protein that drives mammalian cell division
gallus.reactome.org
A function of cyclin D1 in DNA repair uncovered by proteomic screenings
TAP Mass-spec MCF-7, ZR-75-1
UMSCC-2
GRANTA 519
HT29
Jirawatnotai, Nature 2011
Cyclin D1 is required for cell survival after DNA damage
0 h 16 h
sicont
siD1-B0-4
041
-6061
-80
81-10
0>1
000
20
40
60
80 sicont
siD1-B
Tail length (pixels)P
erce
nt o
f ce
lls
0-40
41-60
61-80
81-10
0>1
000
20
40
60
Tail length (pixels)
Per
cent
of
cells
***
*
***0 h 16 h
Pierce A .,et al. 1999
sicon
t
siRAD51
siD1-A
siD1-B
siD1-C
0
20406080
100120
Per
cent
***
sicon
t
siD1-A
+ D1
020406080
100120
Perc
ent
***
Interaction between cyclin D1 and RAD51 facilitates efficient homologous recombination
Valerie et al., 2003 Oncogene
Cyclin D1 directly interacts with RAD51
SP49
Z138C
Granta 519
H2009
ZR-75-1
HT-29
IP RAD IgG WCL
WB: cyclin D1
MCF7
In vivo bindingIn vitro binding
N-terminus domain of cyclin D1 and C-terminus domain of RAD51 are require for the interaction
***
Interaction between cyclin D1 and RAD51 facilitates RAD51 loading to damage foci
0-2 3-9 10-19
0
20
40
60
80
100 4 h
Foci/nucleus
Per
cent
of
cells
***
******
***
**
0-2 3-9 10-19
0
20
40
60
80
100 0 h
Foci/nucleus
Per
cent
of c
ells
0-2 3-9 10-19
0
20
40
60
80
100 2 h
Foci/nucleus
Per
cent
of
cells
*
******
******
*
0-2 3-9 10-19
0
20
40
60
80
100 8 hsicont siD1-A
siD1-C
Foci/nucleus
Perc
ent
of c
ells
******
******
****
0-2 3-9 10-19
0
20
40
60
80
100 6 h
Foci/nucleus
Per
cent
of c
ells
******
******
******
sicont
siD1-A
siD1-C
DAPI RAD51 -H2AX Merge
sicont
siD1-A
siD1-C
+ DNA damage
Cyclin D1 localizes at damaged DNA
IgG
RAD51E2F
40
2
4
6
Before DNA breakAfter DNA break
Fold
enr
ichm
ent
IgG
RAD51E2F
40
2
4
6
8
Fold
enr
ichm
ent
siD1
IgG
Cyclin
D1
E2F4
0
5
10
15
Before DNA breakAfter DNA break
Fold
enr
ichm
ent
IgG
Cyclin
D1
E2F4
05
10152025
Fold
enr
ichm
ent
siD1
Pierce A .,et al. 1999
Targeted ChIP
DAPI - H2AX cyclin D1 Merge
Immunofluorescence
Interaction between cyclin D1 and BRCA2
B2-
1
B2-
3
B2-
4
B2-
5
B2-
6
B2-
7
B2-
8B
2-9
B2-
2
GS
T
Cyclin D1 binding to BRCA2 in vitro(GST-pull-down)
BRCA2+/-H2AX+
siD1-A
sicont
Esashi, et al. 2005
Input GST
RAD51 binding to BRCA2 in vitro(GST-pull-down)
Esashi, et al. 2005Cyclin A/CDK2 phosphorylation
of BRCA2
Nocodazole D1
GST-B2-9
Roscovitin +----+--
++++
Cyclin A
GST-B2-9
RAD51
Cyclin D1
GST B2-9
pull-down
293 cells
Phospho BRCA2 S3291 Kinase assay
Kinase assay
Expression of cyclin D1 helps recruit RAD51 to C-terminus domain of BRCA2 by preventing the inhibitory S3291 phosphorylation by cyclin A/CDK2
Cyclin D1 expression helps recruiting RAD51 to C-ter of BRCA2
Phospho BRCA2 S3291
BRCA2
Cyclin D1
Cyclin B1
Cyclin A2
RAD51
CDK4
b-Actin
Async. G2/M (nocodazole)
- D1 Ro - D1 Ro
Cyclin B1 long exp
293 cells
Cyclin D1 expression prevents B2-9 phosphorylation by CDK2
Lysate +++-
G2/M
siD1
D1 IR Ros-
Phospho BRCA2 S3291
Cyclin D1
Cyclin A2
CDK4
Cyclin B1
RAD51
HeLa cells
Expression of cyclin D1 helps recruit RAD51 to C-terminus domain of BRCA2 by preventing the inhibitory S3291 phosphorylation by cyclin A/CDK2
Depletion of cyclin D1 by siRNA increases S3291 phosphorylation
IP: B2-9
G2
IR (5 Gy) - + - +
Cyclin A2
Cyclin D1
BRCA2S3291
Asynchronous
GST B2-9
Cyclin D1 is recruited to C-terminus of BRCA2 upon DNA damage
WB
In vitro Competition assay
rHA-Cyclin D1
GST-BRCA2 C-Ter (B2-9) - + + + + + - + + + + +
rCyclin - - - -
+ + + + + + + + + + + +
DA
WB: HA
GST
Cyclin D1 controls phosphorylation of C-terminus BRCA2 by competing with cyclin A for BRCA2 binding
Cyclin D1 cooperates with DNA damage to inhibit BRCA2 phosphorylation at Ser3291
Nocodazole
- + - + - + - + - +
IR - - - - - - + + + +
D1 - - - - + + - - + +
Ros - - + + - - - - - -
1 2 3 4 5 6 7 8 9 10
S3291 Ph
cyclin D1
BRCA2
CDK4
actin
IB:γH2AX
cyclin D1
IB:GST
GST pulldown
B2-9
B2-9 S
3291
E0.5 1 2 4 6
Hour after IR
actin
IB:
S3291 Ph
BRCA2
cdc25a
No
IR
aa 20-90 of cyclin D1 is required for BRCA2-C-terminal binding
full-
leng
th
20-2
95
91-2
95
full-
leng
th
20-2
95
91-2
95
B2-5 B2-9 inp
IP
WB: Cyclin D1
full-
leng
th
WB:GST
B2-9 binding domain of cyclin D1 (aa 20-91) is required to prevent CDK2/Cyclin A2 phosphorylation on B2-9
D1 1-295 1-90
IB:GST
cyclin D1
B2-9 kinase assay
cyclin A-CDK2
0 nM 10 nM 20 nM 40 nM0
20
40
60
80
100
120
D1
Concentration of recombinant cyclin D1
Rel
ativ
e p
hosp
hory
latio
n le
vel
cyclin D1
Δ1-90
BSABSA
BSA BSA
Cyclin box domain of cyclin D1 is required for RAD51 and BRCA2 binding
Cyclin box
CDK4/C
yclin
D1
CDK2/C
yclin
A2
Shot exp.
Long exp.
Shot exp.
Long exp.
Shot exp.
Long exp.
GST-B2-5
GST-B2-9
GST-pRb
GST-B2-9
GST-pRb
GST-B2-5
WB: GST
Cyclin D1 that is in complex with CDK4 does not compete with CDK2/cyclin A
Shot exp.
Long exp.
Kinase assay
CDK4/Cyclin D1 CDK2/Cyclin A2
CDK2/Cyclin A2 CDK4/Cyclin D1
GST-B2-9
GST-Cyclin D1
GST-Cyclin A
WB: GST
0 Gy 2 Gy 4 Gy 6 Gy
1
10
100
0 µM1 µM3 µM
Perc
ent s
urvi
val
Cyclin D1 depletion hypersensitizes Rb-negative cancers to IR treatment
Jirawatnotai, Nature 2011
Cyclin D1 promotes RAD51 localization on damage DNA, and HR
Jirawatnotai, Oncogene, in press
No DNA damageSevere DNA damage
Jirawatnotai, Cancer Research, 2012
Thanks
• Chonvara Chalermrujinanant• Gunya Sittithumcharee• Peter Sicinski, DFCI
– Wojtek Michowski– Lisa Becks
• Fumiko Esashi (University of Oxford)
• David Livingston lab, DFCI– Yiduo Hu
• Steve Gygi lab, HMS– Joshua Elias
• John Quackenbush, CCCB, DFCI– Yaoyu Wang
• Bing Xia (University of Medicine and Dentistry• of New Jersey)